Inspired by Nature.
Empowered by Technology.
Committed to Life.
Advancing Human-Relevant Systems to Reduce Reliance on Animal Models
Integrated • Predictive • Translational
Accelerating Smarter, More Human-Relevant Medicine
Translational Portfolio
A Growing Translational Portfolio
NAMina Bio is building more than a catalog of services and products. We are developing an integrated translational architecture where advanced in-vitro technologies, biological models, dynamic culture systems, bioreactors, ECM and 3D culture matrices, synthesis capabilities, analytics, and scientific interpretation can be combined into fit-for-purpose workflows.
Through our curated portfolio, partners can access both translational programs and partner-enabled technologies that may be used within their own laboratories with NAMina’s scientific guidance, study-design support, implementation assistance, and data interpretation.
Our goal is to help academic, biotech, pharma, and technology partners design more predictive, human-relevant studies while reducing reliance on traditional animal models.
Looking for a customized translational workflow?
Many NAMina Bio offerings can be adapted to specific biological questions, disease areas, model systems, and technology requirements. If you are interested in a customized study, feasibility review, technology implementation, partner-enabled product, or integrated NAM-based workflow, please contact us to discuss the best path forward.